Next Financial Group’s Avita Medical RCEL Stock Holding History

Next Financial Group’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	-$3K	–	1604
2020 Q1	$3K	Buy	+100	New	+$4.14K	﹤0.01%	1854

Other funds holding RCEL

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Next Financial Group's RCEL Position: Q2 2020 in Review

Next Financial Group sold out of Avita Medical (RCEL) in Q2 2020, closing a stake of 100 shares — an estimated $3K sold.

Next Financial Group first reported a position in RCEL in Q1 2020 and held it in 1 quarter. The position peaked at $3K in Q1 2020. 34 funds tracked by Wall St. Rank hold RCEL as of Q2 2020.

Next Financial Group reported no remaining Avita Medical position as of Q2 2020 after selling out during the quarter.
Next Financial Group sold 100 Avita Medical shares in Q2 2020, an estimated $3K.
Next Financial Group first reported a position in Avita Medical in Q1 2020 and held it in 1 quarter.
Next Financial Group's Avita Medical position peaked at $3K in Q1 2020.
34 funds tracked by Wall St. Rank held Avita Medical as of Q2 2020.

Based on Next Financial Group's 13F filing for Q2 2020, filed 24 Jul 2020.